Poor quality tests could be 80% inaccurate.

In an update to Spain’s case against poorly sourced and unlicensed COVID-19 tests, comes word from the Czech Republic where tests from Shenzhen Bioeasy Biotechnology were also supplied.

Word in the Czech Republic is that of the 150,000 rapid tests supplied, 80% are deemed faulty. The Czech Republic paid US$5.46 per test, making them above the current market rate for improperly certified or uncertified tests made in China.